There was no significant relationship between hsa-miR-10a-5p and prognostic results of patients with BRCA, although there was significant difference in differential analysis of hsa-miR-10a-5p between paired normal and tumor samples (Fig. 7C) as well as between the groups with high CD24 expression and low CD24 expression (Fig. 7D). Here, CD24 is linked to neoplasm.